Transplantation of an alginate-matrigel matrix containing isolated ovarian cells: First step in developing a biodegradable scaffold to transplant isolated preantral follicles and ovarian cells

Biomaterials

Volumn 33, Issue 26, 2012, Pages 6079-6085

  Vanacker, Julie ^a   Luyckx, Valérie ^a   Dolmans, Marie Madeleine ^a   Des Rieux, Anne ^a   Jaeger, Jonathan ^a   Van Langendonckt, Anne ^a   Donnez, Jacques ^a   Amorim, Christiani A ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Alginate; Artificial ovary; Cancer; Degradation; Matrigel; Ovarian cells

Indexed keywords

ARTIFICIAL OVARY; BIODEGRADABLE SCAFFOLD; BLOOD CAPILLARY; CANCER; CRYOPRESERVED; IN-VITRO; INFLAMMATORY RESPONSE; MATRIGEL; OVARIAN TISSUE; SCAFFOLD DEGRADATION; VASCULARIZATION; VESSEL FORMATION;

ALGINATE; BIOMATERIALS; CELL CULTURE; CELL DEATH; DEGRADATION; DISEASES; MICROCIRCULATION; TISSUE;

SCAFFOLDS (BIOLOGY);

ALGINIC ACID; CD34 ANTIGEN; CD45 ANTIGEN; KI 67 ANTIGEN; MATRIGEL; TISSUE SCAFFOLD;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOGRAFT; BIODEGRADABLE IMPLANT; CAPILLARY; CELL CULTURE; CELL GROWTH; CELL ISOLATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DEGRADATION; FEMALE; IN VITRO STUDY; INFLAMMATION; MOUSE; NICK END LABELING; NONHUMAN; OVARY CELL; OVARY FOLLICLE; PRIORITY JOURNAL; TISSUE TRANSPLANTATION; VASCULARIZATION;

ALGINATES; ANIMALS; APOPTOSIS; CELL PROLIFERATION; COLLAGEN; DRUG COMBINATIONS; FEMALE; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; IMMUNOHISTOCHEMISTRY; LAMININ; MICE; MICROSPHERES; OVARIAN FOLLICLE; OVARY; PROTEOGLYCANS; TISSUE ENGINEERING;

MUS;

EID: 84862863010     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.05.015     Document Type: Article

References (36)

1. Donnez J., Silber S., Andersen C.Y., Demeestere I., Piver P., Meirow D., et al. Children born after autotransplantation of cryopreserved ovarian tissue. A review of 13 live births. Ann Med 2011, 43:437-450.
2. Meirow D., Hardan I., Dor J., Fridman E., Elizur S., Ra'anani H., et al. Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients. Hum Reprod 2008, 23:1007-1013.
3. Dolmans M.M., Marinescu C., Saussoy P., Van Langendonckt A., Amorim C., Donnez J. Reimplantation of cryopreserved ovarian tissue fom patients with acute lymphoblastic leukemia is potentially unsafe. Blood 2010, 116:2908-2914.
4. Luyckx V., Gilliaux S., Amorim C.A., Van Langendonckt A., Donnez J., Dolmans M.M. Transplantation of cryopreserved ovarian tissue from patients with advanced-stage breast cancer cannot be safely performed because of the potential risk of reintroducing malignant cells. J Assist Reprod Genet 2011, 28:1018.
5. Rodgers R.J., Irving-Rodgers H.F., Russell D.L. Extracellular matrix of the developing ovarian follicle. Reproduction 2003, 126:415-424.
6. Dath C., Dethy A., Van Langendonckt A., Van Eyck A.S., Amorim C.A., Luyckx V., et al. Endothelial cells are essential for ovarian stromal tissue restructuring after xenotransplantation of isolated ovarian stromal cells. Hum Reprod 2011, 26:1431-1439.
7. Dolmans M.M., Martinez-Madrid B., Gadisseux E., Guiot Y., Yuan W.Y., Torre A., et al. Short-term transplantation of isolated human ovarian follicles and cortical tissue into nude mice. Reproduction 2007, 134:253-262.
8. Murray A.A., Gosden R.G., Allison V., Spears N. Effect of androgens on the development of mouse follicles growing in vitro. J Reprod Fertil 1998, 113:27-33.
9. Reynaud K., Cortvrindt R., Smitz J., Driancourt M.A. Effects of Kit Ligand and anti-Kit antibody on growth of cultured mouse preantral follicles. Mol Reprod Dev 2000, 56:483-494.
10. Sun A.M., O'Shea G.M., Goosen M.F. Injectable microencapsulated islet cells as a bioartificial pancreas. Appl Biochem Biotechnol 1984, 10:87-99.
11. Ma H.L., Chen T.H., Low-Tone Ho L., Hung S.C. Neocartilage from human mesenchymal stem cells in alginate: implied timing of transplantation. J Biomed Mater Res A 2005, 74:439-446.
12. Cai Z.H., Shi Z.Q., O'Shea G.M., Sun A.M. Microencapsulated hepatocytes for bioartificial liver support. Artif Organs 1988, 12:388-393.
13. Heise M., Koepsel R., Russell A.J., McGee E.A. Calcium alginate microencapsulation of ovarian follicles impacts FSH delivery and follicle morphology. Reprod Biol Endocrinol 2005, 14:47.
14. Amorim C.A., Van Langendonckt A., David A., Dolmans M.M., Donnez J. Survival of human pre-antral follicles after cryopreservation of ovarian tissue, follicular isolation and in vitro culture in a calcium alginate matrix. Hum Reprod 2009, 24:92-99.
15. Shikanov A., Xu M., Woodruff T.K., Shea L.D. Interpenetrating fibrin-alginate matrices for in vitro follicle development. Biomaterials 2009, 30:5476-5485.
16. Xu M., Banc A., Woodruff T.K., Shea L.D. Secondary follicle growth and oocyte maturation by culture in alginate hydrogel following cryopreservation of the ovary or individual follicles. Biotechnol Bioeng 2009, 103:378-386.
17. Ashton R.S., Baneriee A., Punvani S., Schaffer D.V., Kane R.S. Scaffolds based on degradable alginate hydrogels and poly(lactide-co-glycolide) microspheres for stem cell culture. Biomaterials 2007, 28:5518-5525.
18. Alsberg E., Kong H.J., Hirano Y., Smith M.K., Albeiruti A., Mooney D.J. Regulating bone formation via controlled scaffold degradation. J Dent Res 2003, 82:903-908.
19. Kalluri R., Neilson E.G. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003, 112:1776-1784.
20. David A., Dolmans M.M., Van Langendonckt A., Donnez J., Amorim C.A. Immunohistochemical localization of growth factors after cryopreservation and 3 weeks' xenotransplantation of human ovarian tissue. Fertil Steril 2011, 95:1241-1246.
21. Martinez-Madrid B., Camboni A., Dolmans M.M., Nottola S., Van Langendonckt A., Donnez J. Apoptosis and ultrastructural assessment after cryopreservation of whole human ovaries with their vascular pedicle. Fertil Steril 2007, 87:1153-1165.
22. Charbonneau H., Tonks N.K., Walsh K.A., Fischer E.H. The leukocyte common antigen (CD45): a putative receptor-linked protein tyrosine phosphatase. Proc Natl Acad Sci U S A 1988, 188(85):7182-7186.
23. Augst A.D., Kong H.J., Mooney D.J. Alginate hydrogels as biomaterials. Macromol Biosci 2006, 6:623-633.
24. Breguet V., von Stockar U., Marison I.W. Characterization of alginate lyase activity on liquid, gelled, and complexed states of alginate. Biotechnol Prog 2007, 23:1223-1230.
25. Orive G., Carcaboso A.M., Hernández R.M., Gascón A.R., Pedraz J.L. Biocompatibility evaluation of different alginates and alginate-based microcapsules. Biomacromolecules 2005, 6:927-931.
26. West E.R., Xu M., Woodruff T.K., Shea L.D. Physical properties of alginate hydrogels and their effects on in vitro follicle development. Biomaterials 2007, 28:4439-4448.
27. Kleinman H.K., Martin G.R. Matrigel: basement membrane matrix with biological activity. Semin Cancer Biol 2005, 15:378-386.
28. Kubota Y., Kleinman H.K., Martin G.R., Lawley T.J. Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J Cell Biol 1988, 107:1589-1598.
29. Rao R.R., Peterson A.W., Ceccarelli J., Putnam A.J., Stegemann J.P. Matrix composition regulates three-dimensional network formation by endothelial cells and mesenchymal stem cells in collagen/fibrin materials. Angiogenesis 2012, 15:253-264.
30. Johansson U., Rasmusson I., Niclou S.P., Forslund N., Gustavsson L., Nilsson B., et al. Formation of composite endothelial cell-mesenchymal stem cell islets: a novel approach to promote islet revascularization. Diabetes 2008, 57:2393-2401.
31. Ghajar C.M., Blevins K.S., Hughes C.C., George S.C., Putnam A.J. Mesenchymal stem cells enhance angiogenesis in mechanically viable prevascularized tissues via early matrix metalloproteinase upregulation. Tissue Eng 2006, 12:2875-2888.
32. Zacharek A., Chen J., Cui X., Li A., Li Y., Roberts C., et al. Angiopoietin 1/Tie2 and VEGF/Flk1 induced by MSC treatment amplifies angiogenesis and vascular stabilization after stroke. J Cereb Blood Flow Metab 2007, 27:1684-1691.
33. Vériter S., Aouassar N., Adnet P.Y., Paridaens M.S., Stuckman C., Jordan B., et al. The impact of hyperglycemia and the presence of encapsulated islets on oxygenation within a bioartificial pancreas in the presence of mesenchymal stem cells in a diabetic Wistar rat model. Biomaterials 2011, 32:5945-5956.
34. De Vos P., Van Hoogmoed C.G., De Haan B.J., Busscher H.J. Tissue responses against immunoisolating alginate-PLL capsules in the immediate posttransplant period. J Biomed Mater Res 2002, 62:430-437.
35. Van Hoogmoed C.G., Busscher H.J., De Vos P. Fourier transform infrared spectroscopy studies of alginate-PLL capsules with varying compositions. J Biomater Res 2003, 67:172-178.
36. Tracey K.J., Cerami A. Tumor necrosis factor: a pleiotic cytokine and therapeutic target. Annu Rev Med 1994, 45:491-503.